OLDER peopleVACCINESAlthough COVID-19 vaccination remains at the forefront, ACIP has offered guidance on MMR, pneumococcal, influenza, and travel vaccines. Here's a round-up.doi:10.12788/jfp.0559D. Campos-OutcaltThe Journal of family practice...
To develop an effective LNP vector for delivery of COVID-19 mRNA vaccine, two critical factors should be taken into consideration. The first factor is choosing an appropriate cationic or ionizable lipid [16]. Even though both cationic and ionizable lipids could effectively complex RNA, ionizable...
Most of the research conducted on lncRNA differential expression analysis in AF has utilized atrial appendage tissue samples from patients. However, it has been observed that the expression profiles of the left atrial appendage (LAA) and right atrial appendage (RAA) differ from each other [194,19...
1273 vaccine had the highest median levels of S-RBD IgG and NAb, followed by BNT162b, ChAdOx1nCoV-19, and BBIBP-CorV/Coronavac. The levels of S-RBD IgG and NAb in subjects vaccinated with mRNA vaccines were significantly higher than those of non-mRNA vaccines when grouped based on their...
RNA-guided human genome engineering via Cas9. Science 339, 823–826 (2013). Article CAS PubMed PubMed Central Google Scholar Senzer, N. et al. Phase I trial of “bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell” vaccine (FANG) in advanced cancer. Mol. Ther. 20, 679–686 (2012)...
COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant women BACKGROUND: Although emerging data during the SARS-CoV-2 pandemic have demonstrated robust messenger RNA vaccine-induced immunogenicity across populations,... C Atyeo,LL Shook,N Nziza,... - 《...
An mRNA vaccine against SARS-CoV-2—preliminary report. N Engl J Med. 2020;383(20):1920-1931. doi:10.1056/NEJMoa2022483PubMedGoogle ScholarCrossref 5. Walsh EE, Frenck RW Jr, Falsey AR, et al. Safety and immunogenicity of two RNA-based COVID-19 vaccine candidates. ...
A replicating RNA vaccine, formulated with a lipid-based nanoparticle emulsion that goes by the acronym LION, produces antibodies against the COVID-19 coronavirus in mice and primates with a single immunization. These antibodies potently neutralize the v
Dr Malani reported serving on the National Institute of Allergy and Infectious Diseases COVID-19 preventive monoclonal antibody data and safety monitoring board but was not compensated. Dr del Rio reported receiving grants from the NIH/NIAID Emory Vaccine and Treatment Evaluation Unit. Funding/Support...
Vaccination has proven efficacy against COVID-19, yet allergic or adverse reactions have resulted in vaccine hesitancy nationwide. Graded or split dosing of vaccines is a relatively common allergy practice that is understudied for efficacy, particularly for COVID-19. We aimed to compare antibody resp...